Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for thiopurine-related hepatotoxicity in inflammatory bowel disease
2008-005015-17Phase 2Active
- Sponsor
- VU university medical centre
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of acetylcysteine in Drug-induced hepatitis (DILI), sponsored by VU university medical centre. Primary endpoints: Change in aspartate aminotransferase, Change in alanine aminotransferase and 3 more. Started Jan 2009; status: active.
02
Drugs
acetylcysteine
03
Conditions
Drug-induced hepatitis (DILI)
Beyond the preview
Go deeper on 2008-005015-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005015-17.